{"ORPHApacket":[{"ORPHApacketID":"79156","date":"2019-12-05 18:26:39","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"79156","Name":[{"lang":"en","label":"Seizures-intellectual disability due to hydroxylysinuria syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79156","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare syndromic intellectual disability"}],"ORPHA":"102369","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_102369"},{"Name":[{"lang":"en","label":"Neurometabolic disease"}],"ORPHA":"68385","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_68385"},{"Name":[{"lang":"en","label":"Rare genetic syndromic intellectual disability"}],"ORPHA":"183763","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_183763"},{"Name":[{"lang":"en","label":"Disorder of lysine and hydroxylysine metabolism"}],"ORPHA":"289832","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_289832"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Seizures-intellectual disability due to hydroxylysinuria syndrome is characterised by hydroxylysinuria, myoclonic and motor seizures and intellectual deficit. It has been described in a brother and sister born to consanguineous parents and in one unrelated patient."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"236900","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Infancy"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"HPODisorderAssociationList":[{"count":"3","HPODisorderAssociation":[{"HPOId":"HP:0001249","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001249","HPOTerm":"Intellectual disability","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002123","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002123","HPOTerm":"Generalized myoclonic seizures","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0003355","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003355","HPOTerm":"Aminoaciduria","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}